N81 (B2C)
Gender: Male and Female
Smoking habit: Non / Ex-smoker only
Pot smoking
18 - 55
BMI : 18.00 - 30.00
Food restrictions : Fast
Clinic stay
- 7 Nov (07:00) to 20 Nov (09:00)
Return visits
- 24 Nov (08:00)
Participants must be available to stay at our clinic for all of the dates listed above and/or in the notes below. All clinic stays and return visits are mandatory. Times are subject to change.
Medication type
This drug is indicated for potential treatment of cognitive impairment in subjects with dementia including Alzheimer’s disease and schizophrenia.
Notes
PARTICIPANTS WHO HAVE COMPLETED A STUDY IN THE LAST THREE MONTHS PRIOR TO THE START OF THE STUDY ARE NOT ELIGIBLE.
We are seeking men and post-menopausal or surgically sterile women (complete hysterectomy or bilateral oophorectomy).
Phase 1 study.
Six hours fasting before medical exam.
You will receive $100 after completing the medical exam.
Participants must be fasted prior to each dosing.
Participants will remain seated for at least 4 hours after taking the medication.
Blood volume: male 170ml / female 170ml (40 blood draws).
The date for the return visit may be subject to change.
Your medical history and/or medication intake history may affect your participation on this study.
Please note that we are testing for drugs and alcohol during the medical evaluation.
This is preliminary information and changes could occur without notice